关注
Josep Darba
Josep Darba
在 ub.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Situación actual del dolor crónico en España: iniciativa" Pain Proposal"
A Torralba, A Miquel, J Darba
Revista de la Sociedad Española del Dolor 21 (1), 16-22, 2014
1792014
The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients
J Darbà, G Ramírez, A Sicras, P Francoli, S Torvinen, ...
International Journal of Chronic Obstructive Pulmonary Disease, 2335-2345, 2015
602015
Relationship between global severity of patients with Alzheimer’s disease and costs of care in Spain; results from the co-dependence study in Spain
J Darbà, L Kaskens, L Lacey
The European Journal of Health Economics 16, 895-905, 2015
462015
Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study
J Darbà, L Kaskens, N Pérez-Álvarez, S Palacios, JL Neyro, J Rejas
BMC Public Health 15, 1-10, 2015
442015
Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources
J Darbà, A Marsà
BMC cancer 19, 1-7, 2019
412019
Parallel imports of pharmaceuticals in the European Union
J Darbà, J Rovira
Pharmacoeconomics 14 (Suppl 1), 129-136, 1998
401998
Assessment of potential measures in models of progression in Alzheimer disease
T McLaughlin, M Buxton, T Mittendorf, W Redekop, L Mucha, J Darba, ...
Neurology 75 (14), 1256-1262, 2010
342010
A review of the value of innovation in inhalers for COPD and asthma
JC Virchow, CA Akdis, J Darba, R Dekhuijzen, S Hartl, G Kobelt, A Roger, ...
Journal of market access & health policy 3 (1), 28760, 2015
322015
Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain
J Darbà, L Kaskens
ClinicoEconomics and Outcomes Research, 387-395, 2015
292015
A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives
TI Verhoef, WK Redekop, J Darba, M Geitona, DA Hughes, U Siebert, ...
Pharmacogenomics 11 (7), 989-1002, 2010
292010
Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance
J Darbà, G Ramírez, A Sicras, L Garcia-Bujalance, S Torvinen, ...
Patient preference and Adherence, 135-145, 2016
282016
Pharmaceutical pricing and reimbursement in Spain
J Rovira, J Darba
The European Journal of Health Economics 2 (1), 39-43, 2001
282001
Epidemiology and management of parathyroid gland disorders in Spain over 15 years: a retrospective multicentre analysis
J Darbà, A Marsà
PLoS One 15 (3), e0230130, 2020
272020
Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus–from the Spanish National Health …
P Mezquita-Raya, J Darbà, M Ascanio, A Ramirez de Arellano
Expert review of pharmacoeconomics & outcomes research 17 (6), 587-595, 2017
272017
Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: a meta-analysis of randomized clinical trials
J Darbà, A Minoves, E Rojo, F Jimenez, J Rejas
Revista de Psiquiatría y Salud Mental (English Edition) 4 (3), 126-143, 2011
272011
Patient preferences for osteoporosis in Spain: a discrete choice experiment
J Darba, G Restovic, L Kaskens, MA Balbona, A Carbonell, P Cavero, ...
Osteoporosis international 22, 1947-1954, 2011
272011
Pharmaceutical expenditure in Spain: evolution and cost containment measures during 1998–2001
J Darbá
The European Journal of Health Economics, formerly: HEPAC 4, 151-157, 2003
252003
Cost data assessment in multinational economic evaluations: some theory and review of published studies.
RG Halliday, J Darba
Applied health economics and health policy 2 (3), 149-155, 2003
252003
Costs of surviving meningococcal disease in Spain: evaluation for two cases of severe meningitis and septicaemia
J Darbà, L Kaskens, M Hark, C Wright
Vaccine 32 (39), 5006-5012, 2014
232014
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a …
A Sicras-Mainar, L Sánchez-Álvarez, R Navarro-Artieda, J Darbà
Lipids in health and disease 17, 1-16, 2018
222018
系统目前无法执行此操作,请稍后再试。
文章 1–20